ARS Pharmaceuticals, Inc.
SPRY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $7,998 | -$54,365 | -$34,682 | -$20,243 |
| Dep. & Amort. | -$7,175 | $73 | $319 | $213 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $14,534 | $9,235 | $5,843 | $2,829 |
| Change in WC | -$1,809 | -$7,331 | -$12,754 | -$356 |
| Other Non-Cash | $0 | -$6,878 | $1,196 | -$4 |
| Operating Cash Flow | $13,548 | -$59,266 | -$40,078 | -$17,561 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$563 | -$175 | -$199 | -$55 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$356,038 | -$272,005 | $0 | $0 |
| Inv. Sales/Matur. | $258,000 | $185,000 | $0 | $0 |
| Other Inv. Act. | -$7,500 | $0 | $0 | $0 |
| Investing Cash Flow | -$106,101 | -$87,180 | -$199 | -$55 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $69,383 | $0 | -$8,681 | -$1,817 |
| Stock Issued | $3,016 | $6,899 | $570 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $198,843 | $54,975 |
| Financing Cash Flow | $72,399 | $6,899 | $190,732 | $53,158 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$20,154 | -$139,547 | $150,455 | $35,542 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70,971 | $210,518 | $60,063 | $24,521 |
| End Cash | $50,817 | $70,971 | $210,518 | $60,063 |
| Free Cash Flow | $12,985 | -$59,441 | -$40,277 | -$17,616 |